May 14, 2020 Clinical Research/Diagn. Informatics & Software PR/Corporate

Clear Labs Raises $18M; Plans to Expand Application of Automated Next-Generation Sequencing Platform to COVID-19 Diagnostics

Company’s novel characterizing diagnostic could significantly improve testing rates, results, and ability to trace the virus MENLO PARK, CALIF. (PRWEB) MAY 14, 2020 Clear Labs, providers of the only automated and intelligent diagnostic NGS platform, today announced the raise of a $18M strategic round of funding led by Redmile Group, as well as existing investors including... Read more

May 14, 2020 PR/Corporate

Xylem Inc. Declares Second Quarter Dividend of 26 Cents Per Share

RYE BROOK, N.Y.–(BUSINESS WIRE)–May 14, 2020– The Board of Directors of Xylem Inc. (NYSE: XYL) has declared a second quarter dividend of $0.26 per share payable on June 25, 2020, to shareholders of record as of May 28, 2020. Xylem is a leading global water technology company committed to developing innovative technology solutions to the... Read more

May 14, 2020 PR/Corporate

MTS Board Appoints Randy Martinez Interim Chief Executive Officer

EDEN PRAIRIE, Minn., May 14, 2020 /PRNewswire/ — MTS Systems Corporation (Nasdaq: MTSC), a leading global supplier of advanced test systems, motion simulators and precision sensors, today announced that its Board of Directors has unanimously elected Randy J. Martinez as Interim President and Chief Executive Officer, effective May 23, 2020. Mr. Martinez, a seasoned executive who... Read more

May 14, 2020 PR/Corporate

MTS Board Appoints Randy Martinez Interim Chief Executive Officer

EDEN PRAIRIE, Minn., May 14, 2020 /PRNewswire/ — MTS Systems Corporation (Nasdaq: MTSC), a leading global supplier of advanced test systems, motion simulators and precision sensors, today announced that its Board of Directors has unanimously elected Randy J. Martinez as Interim President and Chief Executive Officer, effective May 23, 2020. Mr. Martinez, a seasoned executive who... Read more

May 14, 2020 PR/Corporate

Summary of Financial Results 2020

Home Corporate Guide Message from the president Corporate Data Corporate History Corporate Executives Directions to Takara Bio Sustainability Initiatives Business Outline News Release Investor Relstions Management Policy Financial Data IR Library Stock Information IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide Products Site About Us Business Outline News Release Investor Relstions Japanese... Read more

May 6, 2020 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

Danaher Reports First Quarter 2020 Results

WASHINGTON, May 6, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended April 3, 2020.  All results in this release reflect only continuing operations unless otherwise noted. For the first quarter 2020, net earnings were $595.1 million, or $0.81 per diluted common share.  Non-GAAP adjusted diluted net earnings... Read more

May 6, 2020 PR/Corporate

QIAGEN reports full results for first quarter of 2020

Q1 2020 results: Net sales of $372.1 million (+7% actual, +9% CER vs. ~+2-3% CER outlook) Diluted EPS $0.17; adjusted EPS $0.34 ($0.34 CER vs. ~$0.28-0.29 CER outlook) Fully mobilized teams addressing COVID-19 pandemic testing demand, dramatically ramping up production of RNA extraction kits, QIAstat-Dx tests and components for third-party tests QIAGEN expects higher results... Read more

May 6, 2020 Lab Top-10 PR/Corporate

PerkinElmer Receives AOAC INTERNATIONAL First Action Official Methods of Analysis (OMA) Status for Solus One Salmonella Assay

Highest level of AOAC approval includes testing for foods such as romaine lettuce, raw salmon, dairy products and herbs and spices WALTHAM, Mass. –  May 6, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced its Solus One™ Salmonella assay and methods have been granted First Action Official... Read more

May 5, 2020 Environ, Ag./Food & Bev Lab Top-10 PAI Top-10 PR/Corporate

PerkinElmer Announces Financial Results for the First Quarter of 2020

Revenue of $652.4 million; 1% reported growth; (1)% organic growth GAAP EPS from continuing operations of $0.30; Adjusted EPS of $0.67 Withdrawing previously disseminated FY20 guidance due to COVID-related uncertainties WALTHAM, Mass.–(BUSINESS WIRE)–May 5, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the... Read more